These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2441486)

  • 1. [Changes in blood immunochemical indices in atherosclerosis patients during combined diet and drug therapy].
    Murashko VV; Baranov AP; Kamenets AV; Soldatov DG; Moshkova NK
    Ter Arkh; 1987; 59(5):60-2. PubMed ID: 2441486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunochemical study of the alpha 2-glycoprotein from the atherosclerotically altered aortic wall in the blood serum of ischemic heart disease patients].
    Murashko VV; Baranov AP; Kamenets AV; Tatarinov IuS; Chekhonin VP
    Ter Arkh; 1985; 57(9):37-9. PubMed ID: 2417347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of partial ileoshunting on hyperlipoproteinemia in patients with atherosclerosis].
    Sedletskiĭ IuI
    Vestn Khir Im I I Grek; 1985 Aug; 135(8):48-51. PubMed ID: 4060509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ["Atherosclerosis-index" (LDL/HDL): risk indicator in lipid metabolism disorders].
    Mertz DP
    Med Klin; 1980 Feb; 75(4):159-61. PubMed ID: 7374617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in blood lipoproteins in patients with peripheral atherosclerosis after hemosorption].
    Khalilov EM; Torkhovskaia TI; Ivanov AS; Shingereĭ MV; Perepelitsa VN
    Vopr Med Khim; 1984; 30(6):24-8. PubMed ID: 6528534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atherosclerosis in familial hypercholesteremia possibly induced by defective HDL].
    Breier C; Lisch HJ; Drexel H; Braunsteiner H
    Schweiz Med Wochenschr; 1984 Mar; 114(9):288-91. PubMed ID: 6710113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory parameters as discriminators for peripheral atherosclerosis and stroke.
    Kostner GM; Marth E; Pfeiffer KH; Wege H
    Monogr Atheroscler; 1986; 14():119-23. PubMed ID: 3736549
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of combination of captopril and hydrochlorothiazide on plasma lipids, lipoproteins and apolipoproteins in primary hypertension.
    Lacourcière Y; Gagné C
    J Hum Hypertens; 1993 Apr; 7(2):149-52. PubMed ID: 8510087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the cardiovascular risk associated with atherosclerosis: HDL-cholesterol or apoproteins? (author's transl)].
    Haïat R; Bugugnani MJ
    Nouv Presse Med; 1982 Apr; 11(19):1487-9. PubMed ID: 6804931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis.
    Staprans I; Pan XM; Rapp JH; Feingold KR
    Mol Nutr Food Res; 2005 Nov; 49(11):1075-82. PubMed ID: 16270280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of different LDL-apheresis methods on parameters involved in atherosclerosis.
    Hershcovici T; Schechner V; Orlin J; Harell D; Beigel Y
    J Clin Apher; 2004; 19(2):90-7. PubMed ID: 15274202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemiluminescence of apo-B-lipoproteins in experimental hypercholesterolemia of rabbits].
    Lopukhin IuM; Molodenkov MN; Vladimirov IuA; Sergienko VI; Klebanov GI
    Biull Eksp Biol Med; 1982 Apr; 93(4):101-2. PubMed ID: 7082788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atherosclerosis treatment with etofibrate retard. New perspectives].
    Degenring FH; Schatton W; Hotz W
    Fortschr Med; 1983 Aug; 101(30):1391-6. PubMed ID: 6618402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of low density and high density lipoprotein cholesterol by fat-modified diets. A survey of recent findings.
    Vessby B; Lithell H; Boberg J
    Hum Nutr Clin Nutr; 1982; 36(3):203-11. PubMed ID: 6749766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Morphofunctional state of the digestive tract in the early stages of atherosclerosis].
    Klimenko ED; Lebedeva RP
    Biull Eksp Biol Med; 1975 Jun; 79(6):114-7. PubMed ID: 177121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [High density lipoproteins: the status quo (author's transl)].
    Kostner GM
    Wien Klin Wochenschr; 1980 Oct; 92(19):665-72. PubMed ID: 7467341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum lipids and lipoproteins in patients with cerebrovascular disorders].
    Lorenc J; Kościuk N
    Przegl Lek; 1989; 46(9):681-5. PubMed ID: 2595002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antiatherogenic L-aspartate and L-glutamate on serum lipoproteins cholesterol and apolipoproteins A-1 and B in rabbits fed with high cholesterol diet.
    Yanni AE; Perrea DN; Yatzidis HA
    Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):161-5. PubMed ID: 15955463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fenofibrate: hypolipaemic activity and safety in long-term treatment. Effects on HDL, LDL, VLDL and apoprotein B in short-term treatment (author's transl)].
    Rouffy J; Sauvanet JP; Chanu B; Bakir R; Goy-Loeper J; Saya C; Pinaroli F
    Nouv Presse Med; 1980 Dec; 9(49):3747-51. PubMed ID: 7208341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.